Form 8-K - Current report:
SEC Accession No. 0001096906-16-001710
Filing Date
2016-06-23
Accepted
2016-06-23 07:55:45
Documents
1
Period of Report
2016-06-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. 8K 2016-06-23 aoxing.htm 8-K 29322
  Complete submission text file 0001096906-16-001710.txt   30774
Mailing Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404
Business Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-32674 | Film No.: 161727586
SIC: 2834 Pharmaceutical Preparations